SILK TECHNOLOGIES, LTD.
Plymouth, MN · Founded 2015 · CIK 0001720281 · Medtech · Private
SDP-4 eye drop therapeutic formulation based on silk-derived proteins
silk-tech.com →- Grants
- $1.1M
- 2 awards
- Sector median: 1
- Raised
- $5.0M
- 1 Form D · Oct 2017
- 107 months since last filing
- Contracts
- $4.1M
- 4 awards · Defense
- #138 of 4531 in medtech
- Patents
- 24
- 8 granted · 16 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract· 1 of 2 same day | Department of Defense · Igf::ot::igf Army Phase I Proposal A151-061-0107 | $149,629 | |
| Federal grant· 2 of 2 same day | Department of Defense · Phase I · Topical Therapeutic for Ocular Trauma | $99,890 | |
| Federal contract | Department of Defense · Igf::ot::igf SBIR Phase II H2-0139 | $1,432,105 | |
| Federal contract | Department of Defense · Igf::ot::igf Army SBIR Phase II #A2-6492 | $1,536,826 | |
| Private capital raised | Form D · SEC | $5,000,000 | |
| Federal grant | Department of Defense · Phase II · Topical Therapeutic for Ocular Trauma | $998,884 | |
| Federal contract | Department of Defense · Award Of Silk Technologies' Army SBIR Sequential Phase II Medical R&d Contract For "topical Therapeutic For Ocular Trauma" | $998,884 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 135 | TRACE BIOSCIENCES INC | $4.2M | — |
| 136 | ShockWave Medical, Inc. | $4.2M | $110M |
| 137 | NOWDiagnostics, Inc. | $4.1M | $43M |
| 138 | SILK TECHNOLOGIES, LTD. | $4.1M | $5.0M |
| 139 | Neurable Inc. | $4.1M | $12M |
| 140 | DXDISCOVERY INC | $4.1M | — |
| 141 | SUVICA INC | $4.0M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Emmett CunninghamDirector
- Mark DackoExecutive Officer
- Andrew GitkinDirector
- Brian LawrenceDirector · Executive Officer
- Brian LevyDirector
- Richard LindstromDirector
- William MowerDirector
- Alex SoltaniDirector
Patents
- Fibroin-derived Protein Compositionapplication
- Fibroin-derived Protein Compositiongranted
- Fibroin-derived Protein Compositiongranted
- Stable Formulations Of Silk-derived Proteinapplication
- Silk-derived Protein For Treating Inflammationapplication
- Silk-derived Protein For Treating Inflammationgranted
- Ocular Compositions And Methodsapplication
- Fibroin-derived Protein Compositiongranted
- A Method To Enhance Wound Healing Using Silk-derived Proteingranted
- Fibroin-derived Protein Compositiongranted
- Fibroin-derived Protein Compositiongranted
- Fibroin-derived Protein Compositiongranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.